Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow‐up study

Abstract Introduction Prenatal exposure to supraphysiological glucocorticoid (GC) levels may lead to long‐lasting developmental changes in numerous biological systems. Our prior study identified an association between prenatal GC prophylaxis and reduced cognitive performance, electrocortical changes...

Full description

Saved in:
Bibliographic Details
Main Authors: Florian Rakers, Ekkehard Schleussner, Amani Cornelius, Steffen Kluckow, Isabel Muth, Dirk Hoyer, Sven Rupprecht, Torsten Schultze, Karin Schiecke, Carolin Ligges, Matthias Schwab, Heike Hoyer
Format: Article
Language:English
Published: Wiley 2024-08-01
Series:Acta Obstetricia et Gynecologica Scandinavica
Subjects:
Online Access:https://doi.org/10.1111/aogs.14885
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850211737302728704
author Florian Rakers
Ekkehard Schleussner
Amani Cornelius
Steffen Kluckow
Isabel Muth
Dirk Hoyer
Sven Rupprecht
Torsten Schultze
Karin Schiecke
Carolin Ligges
Matthias Schwab
Heike Hoyer
author_facet Florian Rakers
Ekkehard Schleussner
Amani Cornelius
Steffen Kluckow
Isabel Muth
Dirk Hoyer
Sven Rupprecht
Torsten Schultze
Karin Schiecke
Carolin Ligges
Matthias Schwab
Heike Hoyer
author_sort Florian Rakers
collection DOAJ
description Abstract Introduction Prenatal exposure to supraphysiological glucocorticoid (GC) levels may lead to long‐lasting developmental changes in numerous biological systems. Our prior study identified an association between prenatal GC prophylaxis and reduced cognitive performance, electrocortical changes, and altered autonomic nervous system (ANS) activity in children aged 8–9 years. This follow‐up study aimed to examine whether these findings persisted into adolescence. Material and Methods Prospective observational follow‐up study involving twenty‐one 14‐ to 15‐year‐old adolescents born to mothers who received betamethasone for induction of fetal lung maturation in threatened preterm birth, but who were born with a normal weight appropriate for their gestational age (median 37+4 gestational weeks). Thirty‐five children not exposed to betamethasone served as the reference group (median 37+6 gestational weeks). The primary endpoint was cognitive performance, measured by intelligence quotient (IQ). Key secondary endpoints included symptoms of attention‐deficit/hyperactivity disorder (ADHD) and metabolic markers. Additionally, we determined electrocortical (electroencephalogram), hypothalamus–pituitary–adrenal axis (HPAA), and ANS activity in response to a standardized stress paradigm. Results No statistically significant group difference was observed in global IQ (adjusted mean: betamethasone 103.9 vs references 105.9, mean difference −2.0, 95% confidence interval [CI]: −7.12 to 3.12, p = 0.44). Similarly, ADHD symptoms, metabolic markers, the overall and stress‐induced activity of the HPAA and the ANS did not differ significantly between groups. However, the betamethasone group exhibited reduced electrocortical activity in the frontal brain region (spectral edge frequency–adjusted means: 16.0 Hz vs 17.8 Hz, mean difference −1.83 Hz, 95% CI: −3.21 to −0.45, p = 0.01). Conclusions In 14‐ to 15‐year‐old adolescents, prenatal GC exposure was not associated with differences in IQ scores or ANS activity compared to unexposed controls. However, decelerated electrocortical activity in the frontal region potentially reflects disturbances in the maturation of cortical and/or subcortical brain structures. The clinical significance of these changes remains unknown. Given the small sample size, selective participation/loss of follow‐up and potential residual confounding, these findings should be interpreted cautiously. Further research is required to replicate these results in larger cohorts before drawing firm clinical conclusions.
format Article
id doaj-art-417cf1bea27943f18ef244e8faa8449e
institution OA Journals
issn 0001-6349
1600-0412
language English
publishDate 2024-08-01
publisher Wiley
record_format Article
series Acta Obstetricia et Gynecologica Scandinavica
spelling doaj-art-417cf1bea27943f18ef244e8faa8449e2025-08-20T02:09:30ZengWileyActa Obstetricia et Gynecologica Scandinavica0001-63491600-04122024-08-0110381530154010.1111/aogs.14885Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow‐up studyFlorian Rakers0Ekkehard Schleussner1Amani Cornelius2Steffen Kluckow3Isabel Muth4Dirk Hoyer5Sven Rupprecht6Torsten Schultze7Karin Schiecke8Carolin Ligges9Matthias Schwab10Heike Hoyer11Hans Berger Department of Neurology Jena University Hospital Jena GermanyDepartment of Obstetrics Jena University Hospital Jena GermanyDepartment of Obstetrics Jena University Hospital Jena GermanyHans Berger Department of Neurology Jena University Hospital Jena GermanyDepartment of Obstetrics Jena University Hospital Jena GermanyHans Berger Department of Neurology Jena University Hospital Jena GermanyHans Berger Department of Neurology Jena University Hospital Jena GermanyHans Berger Department of Neurology Jena University Hospital Jena GermanyInstitute of Medical Statistics, Computer and Data Sciences Jena University Hospital Jena GermanyDepartment of Child and Adolescent Psychiatry, Psychosomatic Medicine and Psychotherapy Jena University Hospital Jena GermanyHans Berger Department of Neurology Jena University Hospital Jena GermanyInstitute of Medical Statistics, Computer and Data Sciences Jena University Hospital Jena GermanyAbstract Introduction Prenatal exposure to supraphysiological glucocorticoid (GC) levels may lead to long‐lasting developmental changes in numerous biological systems. Our prior study identified an association between prenatal GC prophylaxis and reduced cognitive performance, electrocortical changes, and altered autonomic nervous system (ANS) activity in children aged 8–9 years. This follow‐up study aimed to examine whether these findings persisted into adolescence. Material and Methods Prospective observational follow‐up study involving twenty‐one 14‐ to 15‐year‐old adolescents born to mothers who received betamethasone for induction of fetal lung maturation in threatened preterm birth, but who were born with a normal weight appropriate for their gestational age (median 37+4 gestational weeks). Thirty‐five children not exposed to betamethasone served as the reference group (median 37+6 gestational weeks). The primary endpoint was cognitive performance, measured by intelligence quotient (IQ). Key secondary endpoints included symptoms of attention‐deficit/hyperactivity disorder (ADHD) and metabolic markers. Additionally, we determined electrocortical (electroencephalogram), hypothalamus–pituitary–adrenal axis (HPAA), and ANS activity in response to a standardized stress paradigm. Results No statistically significant group difference was observed in global IQ (adjusted mean: betamethasone 103.9 vs references 105.9, mean difference −2.0, 95% confidence interval [CI]: −7.12 to 3.12, p = 0.44). Similarly, ADHD symptoms, metabolic markers, the overall and stress‐induced activity of the HPAA and the ANS did not differ significantly between groups. However, the betamethasone group exhibited reduced electrocortical activity in the frontal brain region (spectral edge frequency–adjusted means: 16.0 Hz vs 17.8 Hz, mean difference −1.83 Hz, 95% CI: −3.21 to −0.45, p = 0.01). Conclusions In 14‐ to 15‐year‐old adolescents, prenatal GC exposure was not associated with differences in IQ scores or ANS activity compared to unexposed controls. However, decelerated electrocortical activity in the frontal region potentially reflects disturbances in the maturation of cortical and/or subcortical brain structures. The clinical significance of these changes remains unknown. Given the small sample size, selective participation/loss of follow‐up and potential residual confounding, these findings should be interpreted cautiously. Further research is required to replicate these results in larger cohorts before drawing firm clinical conclusions.https://doi.org/10.1111/aogs.14885fetal physiologyfetal programmingglucocorticoidsneurodevelopmentpreterm birth
spellingShingle Florian Rakers
Ekkehard Schleussner
Amani Cornelius
Steffen Kluckow
Isabel Muth
Dirk Hoyer
Sven Rupprecht
Torsten Schultze
Karin Schiecke
Carolin Ligges
Matthias Schwab
Heike Hoyer
Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow‐up study
Acta Obstetricia et Gynecologica Scandinavica
fetal physiology
fetal programming
glucocorticoids
neurodevelopment
preterm birth
title Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow‐up study
title_full Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow‐up study
title_fullStr Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow‐up study
title_full_unstemmed Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow‐up study
title_short Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow‐up study
title_sort association between prenatal glucocorticoid exposure and adolescent neurodevelopment an observational follow up study
topic fetal physiology
fetal programming
glucocorticoids
neurodevelopment
preterm birth
url https://doi.org/10.1111/aogs.14885
work_keys_str_mv AT florianrakers associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT ekkehardschleussner associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT amanicornelius associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT steffenkluckow associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT isabelmuth associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT dirkhoyer associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT svenrupprecht associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT torstenschultze associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT karinschiecke associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT carolinligges associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT matthiasschwab associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy
AT heikehoyer associationbetweenprenatalglucocorticoidexposureandadolescentneurodevelopmentanobservationalfollowupstudy